Glenmark Pharmaceuticals Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Xmet-Trio 500/0.2/1 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults.
Tablet ER
Xmet-Trio 500/0.2/1 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Xmet-Trio 500/0.2/1 Tablet ER is to be taken empty stomach.
Xmet-Trio 500/0.2/1 Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Xmet-Trio 500/0.2/1 Tablet ER is a combination medication containing glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in conjunction with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, metformin reduces glucose production in the liver and improves insulin sensitivity, and voglibose lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Xmet-Trio 500/0.2/1 Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your healthcare provider for guidance.
Xmet-Trio 500/0.2/1 Tablet ER is contraindicated in patients with known allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your healthcare provider before taking this medication if you have any of these conditions.
No, it is not recommended to consume alcohol while taking Xmet-Trio 500/0.2/1 Tablet ER. This combination may increase the risk of hypoglycemia and lactic acidosis. Avoid drinking alcohol while taking this medication.
Yes, Xmet-Trio 500/0.2/1 Tablet ER can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice with you to manage hypoglycemia.
Store Xmet-Trio 500/0.2/1 Tablet ER in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.